ViroVentures
Business & Corporate Development
Eric Claassen, Ph.D.
James H.M. Simon D.Phil., M.B.A.
Members

Virus discovery to identify new
vaccine and diagnostic targets

Development of diagnostics and
treatments for hMPV

Diagnostic services and
contract research
News
ViroNovative BV Enters into Worldwide Licensing Agreement for Rapid Detection of hMPV with Diagnostic HYBRIDS
Rotterdam, Netherlands – ViroNovative BV and Diagnostic HYBRIDS have entered into a worldwide licensing agreement covering immunofluorescence-based di...
CoroNovative BV to use Viroscope as a new tradename
Rotterdam, the Netherlands, Nov.8, 2006 - CoroNovative BV has announced that it will use Viroscope as a new tradename.
The use of this new tradename ...

CoroNovative and Nobilon join forces in virus discovery program
Rotterdam, the Netherlands, June 14, 2006 - CoroNovative BV to expand and accelerate its virus discovery program with the help of Akzo Nobel's Nobilon...
Launch of ViroVentures
Rotterdam, the Netherlands, July 1st, 2006 - ViroClinics BV, ViroNovative BV and Viroscope launch ViroVentures, a virtual organization in which the bu...